Halozyme (HALO) Says Prandial Insulin + rHuPH20 Phase 2 Met Primary Endpoint in Type 1 Diabetes Patients

Go back to Halozyme (HALO) Says Prandial Insulin + rHuPH20 Phase 2 Met Primary Endpoint in Type 1 Diabetes Patients